Market5 years ago
Jazz Pharmaceuticals (NASDAQ:JAZZ), Palo Alto Networks (NYSE:PANW) Are Notable Winners To Watch
Jazz Pharmaceuticals (NASDAQ:JAZZ) Q4 results ($M): Revenues: 476.5 (+9.2%). Key product sales: Xyrem: 374.8 (+19.9%); Erwinaze: 24.3 (-49.2%); Vyxeos: 25.6 (+6.2%); Defitelio: 37.7 (+3.9%). Net income:...